Manufacturer's investigation conclusion: a direct correlation between heartmate 3 lvas, serial number (b)(6), and the reported ventricular tachycardia could not be determined through this evaluation.The patient underwent a transplant on (b)(6) 2019.The patient was experiencing recurring ventricular tachycardia that the account believed may have been caused by possible positional issues from initial surgeries.It was also reported that the patient no longer required circulatory support, and that there were no device issues or malfunctions.(b)(6) was not returned for investigation.The heartmate 3 lvas ifu lists cardiac arrhythmia as an adverse event that may be associated with the use of the heartmate 3 left ventricular assist system.The heartmate 3 left ventricular assist system (lvas) instructions for use (ifu) is currently available.Section 1 of this ifu lists cardiac arrhythmia as an adverse event that may be associated with the use of the heartmate 3 lvas.Section 6 of this ifu lists arrhythmia as a potential late postimplant complication.No further information was provided.The manufacturer is closing the file on this event.
|